U.S. Food and Drug Administration

Generic Initiative for Value and Efficiency (GIVE)

Topics on this Page


On October 4, 2007, FDA launched the Generic Initiative for Value and Efficiency, or GIVE. The initiative will use existing resources to help FDA modernize and streamline the generic drug approval process.

GIVE aims to increase the number and variety of generic drug products available. Having more generic-drug options means more cost-savings to consumers, as generic drugs cost about 30 percent to 80 percent less than brand name drugs.

Generic drugs are identical to their brand-name counterparts in dosage form, safety, strength, route of administration, quality, performance, and intended use. Generics also go through a rigorous scientific review to ensure both safety and effectiveness.

What Is FDA Doing?

Frequently Asked Questions

News Updates

Related FDA Web Sites

VIDEOStill image of pharmacist behind cash register from Generic Initiative for Value and Efficiency (GIVE) Video

Windows Media Player
56K | 150K | 300K

Real Player
56K | 150K | 300K

Audio Only (MP3)


Generic Initiative for Value and Efficiency Graphic of person doing paperwork and a computer from GIVE diagram

HTML | PDF (330K)
A diagram of how FDA is making generic drugs available more quickly.


PDF documents may be read with a free copy of the Adobe Acrobat Reader. Excel documents can be read with a free copy of Microsoft's Excel viewer .



rule link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page